Celsion (CLSN) Reports Q2 Loss of $0.46
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Celsion Corporation Reports Second Quarter 2018 Financial Results and Provides Business Update
August 14, 2018 8:30 AM EDTÂ Strong Balance Sheet With Cash Sufficient to Fund Operations Into the First Half of 2020
Quarterly and Year-to-Date Cash Expenses Consistent With Prior Guidance             Company to Hold Conference Call on Tuesday, August 14, 2018 at 11:00 a.m. EDT
LAWRENCEVILLE, N.J., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced financial results for the... More
